Geode Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-272,015
| Closed | -$4.02M | – | 4719 |
|
|
2024
Q1 | $4.02M | Buy |
272,015
+12,069
| +5% | +$170K | ﹤0.01% | 2815 |
|
|
2023
Q4 | $3.49M | Buy |
259,946
+8,361
| +3% | +$106K | ﹤0.01% | 2879 |
|
|
2023
Q3 | $3.1M | Buy |
251,585
+7,783
| +3% | +$94.2K | ﹤0.01% | 2882 |
|
|
2023
Q2 | $3M | Buy |
243,802
+113,638
| +87% | +$1.42M | ﹤0.01% | 2970 |
|
|
2023
Q1 | $1.6M | Sell |
130,164
-4,062
| -3% | -$47.7K | ﹤0.01% | 3125 |
|
|
2022
Q4 | $1.54M | Buy |
134,226
+33,418
| +33% | +$275K | ﹤0.01% | 3163 |
|
|
2022
Q3 | $378K | Hold |
100,808
| – | – | ﹤0.01% | 3879 |
|
|
2022
Q2 | $599K | Buy |
100,808
+1,146
| +1% | +$6.47K | ﹤0.01% | 3665 |
|
|
2022
Q1 | $630K | Buy |
99,662
+2,970
| +3% | +$16.7K | ﹤0.01% | 3828 |
|
|
2021
Q4 | $378K | Hold |
96,692
| – | – | ﹤0.01% | 4186 |
|
|
2021
Q3 | $467K | Hold |
96,692
| – | – | ﹤0.01% | 4062 |
|
|
2021
Q2 | $617K | Buy |
96,692
+5,484
| +6% | +$36.2K | ﹤0.01% | 3841 |
|
|
2021
Q1 | $572K | Buy |
91,208
+7,724
| +9% | +$55.2K | ﹤0.01% | 3757 |
|
|
2020
Q4 | $575K | Hold |
83,484
| – | – | ﹤0.01% | 3546 |
|
|
2020
Q3 | $333K | Buy |
83,484
+2,337
| +3% | +$8.59K | ﹤0.01% | 3565 |
|
|
2020
Q2 | $270K | Hold |
81,147
| – | – | ﹤0.01% | 3578 |
|
|
2020
Q1 | $174K | Hold |
81,147
| – | – | ﹤0.01% | 3591 |
|
|
2019
Q4 | $255K | Buy |
81,147
+249
| +0.3% | +$997 | ﹤0.01% | 3719 |
|
|
2019
Q3 | $363K | Sell |
80,898
-21,923
| -21% | -$110K | ﹤0.01% | 3580 |
|
|
2019
Q2 | $489K | Hold |
102,821
| – | – | ﹤0.01% | 3477 |
|
|
2019
Q1 | $562K | Sell |
102,821
-3,672
| -3% | -$16.9K | ﹤0.01% | 3396 |
|
|
2018
Q4 | $323K | Buy |
106,493
+729
| +0.7% | +$2.53K | ﹤0.01% | 3530 |
|
|
2018
Q3 | $443K | Buy |
105,764
+1,109
| +1% | +$4.67K | ﹤0.01% | 3506 |
|
|
2018
Q2 | $404K | Sell |
104,655
-35,001
| -25% | -$232K | ﹤0.01% | 3512 |
|
|
2018
Q1 | $884K | Buy |
139,656
+1,599
| +1% | +$13.2K | ﹤0.01% | 3178 |
|
|
2017
Q4 | $1.11M | Buy |
138,057
+6,558
| +5% | +$61.1K | ﹤0.01% | 3047 |
|
|
2017
Q3 | $1.5M | Buy |
131,499
+3,916
| +3% | +$41.2K | ﹤0.01% | 2911 |
|
|
2017
Q2 | $1.24M | Buy |
127,583
+517
| +0.4% | +$10.6K | ﹤0.01% | 3008 |
|
|
2017
Q1 | $3.08M | Buy |
127,066
+5,363
| +4% | +$134K | ﹤0.01% | 2403 |
|
|
2016
Q4 | $3.91M | Buy |
121,703
+14,542
| +14% | +$620K | ﹤0.01% | 2219 |
|
|
2016
Q3 | $5.35M | Buy |
107,161
+2,522
| +2% | +$105K | ﹤0.01% | 1929 |
|
|
2016
Q2 | $4.44M | Buy |
104,639
+6,295
| +6% | +$343K | ﹤0.01% | 1994 |
|
|
2016
Q1 | $6.48K | Buy |
98,344
+5,624
| +6% | +$294K | ﹤0.01% | 1693 |
|
|
2015
Q4 | $5.76M | Buy |
92,720
+8,897
| +11% | +$626K | ﹤0.01% | 1778 |
|
|
2015
Q3 | $5.61M | Sell |
83,823
-1,740
| -2% | -$142K | ﹤0.01% | 1770 |
|
|
2015
Q2 | $8.32M | Buy |
85,563
+979
| +1% | +$93.2K | ﹤0.01% | 1548 |
|
|
2015
Q1 | $7.91M | Buy |
84,584
+6,373
| +8% | +$542K | ﹤0.01% | 1559 |
|
|
2014
Q4 | $6.95M | Buy |
78,211
+12,244
| +19% | +$892K | ﹤0.01% | 1611 |
|
|
2014
Q3 | $4.56M | Buy |
65,967
+55
| +0.1% | +$2.94K | ﹤0.01% | 1821 |
|
|
2014
Q2 | $3.78M | Buy |
65,912
+445
| +0.7% | +$22.6K | ﹤0.01% | 1960 |
|
|
2014
Q1 | $2.6M | Buy |
65,467
+6,383
| +11% | +$273K | ﹤0.01% | 2187 |
|
|
2013
Q4 | $2.48M | Buy |
59,084
+4,627
| +8% | +$134K | ﹤0.01% | 2157 |
|
|
2013
Q3 | $1.63M | Buy |
54,457
+40,397
| +287% | +$1.41M | ﹤0.01% | 2295 |
|
|
2013
Q2 | $744K | Buy |
+14,060
| New | +$616K | ﹤0.01% | 2635 |
|
Other funds holding MACK
RA
JC
